SMARCA4 and cancer: The degree analysis of this bipartite network suggests that TP53 occurs in almost all cancer types (Olivier et al., 2010), followed by PIK3CA and SMARCA4 occurring in nine cancer types, indicating their importance in multiple cancers (Kang et al., 2020; Peng et al., 2021).